BioInformant

Your Global Leader in Stem Cell Market Research

Evia Bio® Announces Availability of GMP-Grade CellShield™ MSC DMSO-Free Cryopreservation Media

By Leave a Comment

MINNEAPOLIS, MN – October 28th, 2026 – Evia Bio®, a leading provider of non-dimethyl sulfoxide (non-DMSO) cryopreservation solutions for the cell therapy and in vitro fertilization industries, today announced the GMP grade of CellShield™ cryopreservation media is now available for product shipment to customers.

The CellShield product line is DMSO-free and includes a controlled rate freezing program that optimizes viability, recovery and functionality. GMP grade CellShield MSC is now available for purchase via the Evia Bio website and direct shipment from the manufacturer. [Read more…]

Overcoming major challenges in cardiac drug discovery using human induced pluripotent stem cell technology

By Leave a Comment

Source/Author: Ncardia, Galileiweg 8 | 2333 BD Leiden | The Netherlands
Highlights
  • The biggest opportunity for success in cardiac drug discovery and development is to make these processes more efficient and affordable, since they carry relatively higher risk of clinical trial failure compared to other disciplines.
  • Human iPSC technology is increasingly utilized to develop disease models that reliably mimic the diversity of patient pathogenicity and disease severity in vitro.
  • Phenotypic screening based on iPSC-derived disease models is making cardiac drug discovery more time and cost effective by enabling target-agnostic studies and increasing the translational power of early drug discovery outcomes.

[Read more…]

The Exosome Revolution is Here: 1 in 7 Publications Emerged in the Past Year

By Leave a Comment

Exosomes have recently exploded in popularity, with companies developing exosome-based diagnostics, therapeutics, and cosmeceuticals. Although they were discovered more than 30 years ago, it was not until recently that the scientific community began to give credit to exosomes for a range of promising traits. [Read more…]

Basecamp Research Raises $140M to Advance AI-Designed In Vivo Cell Therapies

By Leave a Comment

NEWS PROVIDED BY Basecamp Research, Sept 23, 2026, 09:06 ET
  • Oversubscribed Series C led by S32 with backing from NVIDIA, Menlo Ventures’ Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI, and True Ventures.
  • Funding will advance a pipeline of EDEN-designed therapeutics, starting with in vivo cell therapy, and expand pharmaceutical partnerships
  • The company has demonstrated strong preclinical results across multiple modalities and disease areas

[Read more…]

Made Scientific Expands U.S. GMP Cell Therapy Network with 85,000 Sq. Ft. Pennsylvania Acquisition — Operational on Day One

By Leave a Comment

NEWS PROVIDED BY Made Scientific, Inc., Sept 21, 2026, 09:06 ET
Facility brings Made Scientific’s U.S. East Coast footprint to 145,000 sq. ft. and 15 qualified GMP manufacturing suites

PRINCETON, N.J., Sept. 21, 2026 — Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and manufacturing organization (CDMO), today announced it has acquired an 85,000 sq. ft. clinical to commercial-scale cell therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience. The transaction closed on September 18, 2026. The facility is operational on close, eliminating the ramp-up and qualification timelines that follow a greenfield build — a critical advantage as therapies advance through late-stage development toward commercial launch. The site and its manufacturing team have executed 145 GMP batches to date across multiple autologous and allogeneic programs, including CAR-T and B-cell therapies. Sponsors can begin onboarding programs immediately, positioning therapies for 2027 clinical and commercial supply. [Read more…]

Shopping cart0
There are no products in the cart!
Continue shopping
0